BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Increlex® 10 mg/ml solution for injection

Active substance: mecasermin, recombinant human IGF-1

The company Ipsen Pharma GmbH is sending out information that the supply with Increlex® (mecasermin) is no longer interrupted.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 180KB, File is accessible